| Altea Therapeutics Corporation |
|
|
2056 Weems Road
Tucker, GA 30084 USA
phone:
678 495 3100
fax:
675 495 3130 |
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
www.alteatherapeutics.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Needleless injection technology enabling the delivery of most drugs. |
 |
| Management |
| Eric Tomlinson, DSc, PhD, President and Chief Executive Officer; David Enscore, Senior Vice President, Product Research and Development; Ross Durland, Vice President, Product Development; Steven Damon, Vice President, Business Development; Alan Smith, PhD, Vice President, Product Development; Michael Hatch, Vice President, Engineering; Frank Tagliaferri, Vice President, Pharmaceutical Sciences; Stuart McRae, PE, Vice President, Commercial Design and Manufacturing; Joe Garcia, Vice President, Human Resources |
|
|
|
|
| Keywords |
| drugs, delivery, therapeutics, vaccines, small molecules, pain, needle free, injection |
|
|
|
|
Description |
| Altea Therapeutics develops MicroPor technology for drug delivery applications, including delivery of peptides and proteins, and small molecules such as pain medications. |
 |
| Technology / Differentiation |
| Altea Therapeutics' MicroPor system is a "needleless injection" technology that enables the delivery of almost any desired drug, regardless of size or molecular weight, directly through the skin without using a needle or other invasive technique. The MicroPor system is painless, rapid, cosmetically appealing, and provides controlled delivery of proteins, DNA, as well as small molecule drugs over a one day to one week time period. |
 |
 |
|
|
|
|